Pendal Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Pendal Group's LLY Position: Q4 2022 in Review
Pendal Group reduced its Eli Lilly (LLY) stake by 18% in Q4 2022, selling an estimated $1.54M and leaving 20,089 shares worth $7.35M. The position accounts for 0.06% of the portfolio, ranked #127.
Pendal Group first reported a position in LLY in Q2 2017 and has held it in 21 quarters since. The position peaked at $9.45M in Q2 2019. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.
- Pendal Group held 20,089 shares of Eli Lilly worth $7.35M as of Q4 2022.
- Pendal Group sold 4,339 Eli Lilly shares in Q4 2022, an estimated $1.54M.
- Eli Lilly made up 0.06% of Pendal Group's portfolio in Q4 2022, its #127 holding.
- Pendal Group first reported a position in Eli Lilly in Q2 2017 and has held it in 21 quarters since.
- Pendal Group's Eli Lilly position peaked at $9.45M in Q2 2019.
- 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.
Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.